HERPUD2
geneOn this page
Also known as FLJ22313
Summary
HERPUD2 (HERPUD family member 2, HGNC:21915) is a protein-coding gene on chromosome 7p14.2, encoding Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein (Q9BSE4). Could be involved in the unfolded protein response (UPR) pathway.
Predicted to be involved in endoplasmic reticulum unfolded protein response. Predicted to be located in membrane.
Source: NCBI Gene 64224 — RefSeq curated summary.
At a glance
- GWAS associations: 55
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_022373
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21915 |
| Approved symbol | HERPUD2 |
| Name | HERPUD family member 2 |
| Location | 7p14.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22313 |
| Ensembl gene | ENSG00000122557 |
| Ensembl biotype | protein_coding |
| OMIM | 620829 |
| Entrez | 64224 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 22 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000311350, ENST00000396081, ENST00000413517, ENST00000426180, ENST00000427455, ENST00000438224, ENST00000603731, ENST00000894703, ENST00000894704, ENST00000894705, ENST00000894706, ENST00000894707, ENST00000894708, ENST00000894709, ENST00000894710, ENST00000894711, ENST00000894712, ENST00000894713, ENST00000894714, ENST00000894715, ENST00000894716, ENST00000894717, ENST00000924127
RefSeq mRNA: 1 — MANE Select: NM_022373
NM_022373
CCDS: CCDS5446
Canonical transcript exons
ENST00000311350 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000832342 | 35670215 | 35670328 |
| ENSE00000976571 | 35673201 | 35673278 |
| ENSE00001023010 | 35694184 | 35694627 |
| ENSE00001189319 | 35694801 | 35695135 |
| ENSE00001523804 | 35632659 | 35633851 |
| ENSE00003484715 | 35667434 | 35667588 |
| ENSE00003549132 | 35634312 | 35634429 |
| ENSE00003609476 | 35635135 | 35635458 |
| ENSE00003689698 | 35638350 | 35638472 |
Expression profiles
Bgee: expression breadth ubiquitous, 260 present calls, max score 96.77.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.1722 / max 519.5978, expressed in 1818 samples.
FANTOM5 promoters (13 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83557 | 16.5051 | 1789 |
| 83554 | 5.5807 | 1564 |
| 83550 | 3.4061 | 1542 |
| 83556 | 3.2064 | 1255 |
| 83551 | 2.9703 | 1510 |
| 83555 | 1.7595 | 1003 |
| 83559 | 1.0954 | 751 |
| 83548 | 0.7006 | 317 |
| 83553 | 0.4311 | 148 |
| 83552 | 0.4235 | 179 |
Top tissues by expression
260 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cauda epididymis | UBERON:0004360 | 96.77 | gold quality |
| caput epididymis | UBERON:0004358 | 96.65 | gold quality |
| buccal mucosa cell | CL:0002336 | 96.52 | gold quality |
| corpus epididymis | UBERON:0004359 | 96.29 | gold quality |
| oral cavity | UBERON:0000167 | 96.00 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 95.95 | gold quality |
| amniotic fluid | UBERON:0000173 | 95.38 | gold quality |
| adult organism | UBERON:0007023 | 95.11 | gold quality |
| synovial joint | UBERON:0002217 | 94.99 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 94.93 | gold quality |
| superficial temporal artery | UBERON:0001614 | 94.45 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 94.30 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 93.95 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 93.84 | gold quality |
| thymus | UBERON:0002370 | 93.77 | gold quality |
| upper arm skin | UBERON:0004263 | 93.74 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 93.47 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.44 | gold quality |
| penis | UBERON:0000989 | 93.35 | gold quality |
| jejunal mucosa | UBERON:0000399 | 93.27 | gold quality |
| superior surface of tongue | UBERON:0007371 | 93.11 | gold quality |
| bone element | UBERON:0001474 | 92.97 | gold quality |
| lower lobe of lung | UBERON:0008949 | 92.88 | gold quality |
| cerebellar vermis | UBERON:0004720 | 92.86 | gold quality |
| urethra | UBERON:0000057 | 92.79 | gold quality |
| blood | UBERON:0000178 | 92.64 | gold quality |
| upper leg skin | UBERON:0004262 | 92.55 | gold quality |
| bone marrow | UBERON:0002371 | 92.49 | gold quality |
| oocyte | CL:0000023 | 92.42 | gold quality |
| oviduct epithelium | UBERON:0004804 | 92.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
94 targeting HERPUD2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-22-3P | 99.93 | 68.13 | 917 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | herpud2 | ENSDARG00000021033 |
| mus_musculus | Herpud2 | ENSMUSG00000008429 |
| rattus_norvegicus | Herpud2 | ENSRNOG00000029995 |
| drosophila_melanogaster | Herp | FBGN0031950 |
| caenorhabditis_elegans | tag-353 | WBGENE00009112 |
Paralogs (1): HERPUD1 (ENSG00000051108)
Protein
Protein identifiers
Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein — Q9BSE4 (reviewed: Q9BSE4)
All UniProt accessions (5): C9J4Q7, C9JDD7, C9JV48, Q9BSE4, S4R420
UniProt curated annotations — full annotation on UniProt →
Function. Could be involved in the unfolded protein response (UPR) pathway.
Subcellular location. Membrane.
RefSeq proteins (1): NP_071768* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000626 | Ubiquitin-like_dom | Domain |
| IPR029071 | Ubiquitin-like_domsf | Homologous_superfamily |
| IPR039751 | HERPUD1/2 | Family |
Pfam: PF00240
UniProt features (19 total): strand 6, compositionally biased region 3, helix 2, turn 2, sequence variant 2, chain 1, transmembrane region 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2KDB | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BSE4-F1 | 61.82 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 168 (showing top):
AAGCAAT_MIR137, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_MALE_GAMETE_GENERATION, LHX3_01, CHX10_01, GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN, AFP1_Q6, MYB_Q3, ELK1_01, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN, TAATTA_CHX10_01, ATGTACA_MIR493
GO Biological Process (3): spermatogenesis (GO:0007283), endoplasmic reticulum unfolded protein response (GO:0030968), response to unfolded protein (GO:0006986)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular response to unfolded protein | 1 |
| response to endoplasmic reticulum stress | 1 |
| intracellular signal transduction | 1 |
| response to topologically incorrect protein | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
576 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HERPUD2 | INTS15 | Q96N11 | 499 |
| HERPUD2 | FAM8A1 | Q9UBU6 | 494 |
| HERPUD2 | OGFOD1 | Q8N543 | 470 |
| HERPUD2 | TMUB2 | Q71RG4 | 455 |
| HERPUD2 | OR4F6 | Q8NGB9 | 433 |
| HERPUD2 | TMUB1 | Q9BVT8 | 406 |
| HERPUD2 | NUDCD3 | Q8IVD9 | 381 |
| HERPUD2 | OR52E4 | Q8NGH9 | 379 |
| HERPUD2 | NT5DC4 | Q86YG4 | 377 |
| HERPUD2 | MRM2 | Q9UI43 | 373 |
| HERPUD2 | FBXO42 | Q6P3S6 | 371 |
| HERPUD2 | SGSM2 | O43147 | 370 |
| HERPUD2 | METTL25B | Q96FB5 | 370 |
| HERPUD2 | RNF185 | Q96GF1 | 362 |
| HERPUD2 | ZDHHC4 | Q9NPG8 | 362 |
IntAct
62 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| TMBIM6 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC35A4 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HERPUD2 | SLC39A9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A13 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HERPUD2 | TAS2R10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFNA5 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ALG10 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM144 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HERPUD2 | IER3IP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NAF1 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBE2B | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYB561A3 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPTSSA | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HERPUD2 | TMEM60 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC7A1 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GATAD1 | SIN3B | psi-mi:“MI:0914”(association) | 0.350 |
| RNASEH2B | SAP18 | psi-mi:“MI:0914”(association) | 0.350 |
| NEDD1 | ATP5MF-PTCD1 | psi-mi:“MI:0914”(association) | 0.350 |
| POLR1C | BDP1 | psi-mi:“MI:0914”(association) | 0.350 |
| TMBIM6 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC35A4 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC39A9 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| IER3IP1 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NAF1 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBE2B | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CYB561A3 | HERPUD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): HERPUD2 (Affinity Capture-MS), HERPUD2 (Affinity Capture-MS), HERPUD2 (Affinity Capture-MS), HERPUD2 (Two-hybrid), HERPUD2 (Two-hybrid), HERPUD2 (Two-hybrid), HERPUD2 (Two-hybrid), IER3IP1 (Two-hybrid), TMEM60 (Two-hybrid), ALG10 (Two-hybrid), SLC7A1 (Two-hybrid), TMBIM6 (Two-hybrid), NAF1 (Two-hybrid), CYB561A3 (Two-hybrid), TMEM144 (Two-hybrid)
ESM2 similar proteins: A0A1L8GLK3, A0A974CYQ5, D2HWM5, D5LXJ0, P49950, P54731, Q0P5H8, Q15011, Q1LZE1, Q28DF1, Q3ZBU9, Q5HZY0, Q5R4I3, Q5R5B0, Q5XHH7, Q66HH4, Q6GPB6, Q6NRL6, Q6NYI0, Q6PCD5, Q6PCP5, Q6R755, Q7T321, Q7ZXQ3, Q803I8, Q80UY2, Q84L31, Q86TM6, Q8BGE4, Q8CIK8, Q8R317, Q8R3V6, Q8VCH8, Q924K2, Q92537, Q92575, Q96D05, Q9BSE4, Q9D882, Q9DBY1
Diamond homologs: Q0P5H8, Q15011, Q28DF1, Q5R5B0, Q66HH4, Q6NYI0, Q7ZXQ3, Q9BSE4, Q9JJC9, Q9JJK5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1572 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:35633847:CGCTC:C | acceptor_gain | 1.0000 |
| 7:35633852:C:CC | acceptor_gain | 1.0000 |
| 7:35633853:T:C | acceptor_gain | 1.0000 |
| 7:35634310:A:AC | donor_gain | 1.0000 |
| 7:35634310:A:C | donor_loss | 1.0000 |
| 7:35634311:C:CC | donor_gain | 1.0000 |
| 7:35634425:GGTGT:G | acceptor_gain | 1.0000 |
| 7:35634427:TGT:T | acceptor_gain | 1.0000 |
| 7:35634427:TGTC:T | acceptor_loss | 1.0000 |
| 7:35634428:GT:G | acceptor_gain | 1.0000 |
| 7:35634430:C:CC | acceptor_gain | 1.0000 |
| 7:35634430:C:T | acceptor_loss | 1.0000 |
| 7:35634435:C:CT | acceptor_gain | 1.0000 |
| 7:35634436:A:T | acceptor_gain | 1.0000 |
| 7:35634437:G:C | acceptor_gain | 1.0000 |
| 7:35634437:G:GC | acceptor_gain | 1.0000 |
| 7:35634442:A:AC | acceptor_gain | 1.0000 |
| 7:35634442:A:C | acceptor_gain | 1.0000 |
| 7:35635199:CAATG:C | donor_gain | 1.0000 |
| 7:35635219:G:C | donor_gain | 1.0000 |
| 7:35635238:T:TA | donor_gain | 1.0000 |
| 7:35638348:A:AC | donor_gain | 1.0000 |
| 7:35638349:C:CC | donor_gain | 1.0000 |
| 7:35638349:CTA:C | donor_gain | 1.0000 |
| 7:35638349:CTACT:C | donor_gain | 1.0000 |
| 7:35667432:A:AC | donor_gain | 1.0000 |
| 7:35667432:AC:A | donor_gain | 1.0000 |
| 7:35667432:ACC:A | donor_gain | 1.0000 |
| 7:35667433:C:CC | donor_gain | 1.0000 |
| 7:35667433:CC:C | donor_gain | 1.0000 |
AlphaMissense
2676 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:35670303:A:G | L84P | 1.000 |
| 7:35673259:A:G | L56S | 1.000 |
| 7:35694217:T:A | K38N | 1.000 |
| 7:35694217:T:G | K38N | 1.000 |
| 7:35694221:A:G | L37P | 1.000 |
| 7:35633724:A:G | L396P | 0.999 |
| 7:35635203:G:C | S291R | 0.999 |
| 7:35635203:G:T | S291R | 0.999 |
| 7:35635205:T:G | S291R | 0.999 |
| 7:35670305:A:C | H83Q | 0.999 |
| 7:35670305:A:T | H83Q | 0.999 |
| 7:35670307:G:C | H83D | 0.999 |
| 7:35670309:A:T | V82D | 0.999 |
| 7:35673238:A:G | L63P | 0.999 |
| 7:35673238:A:T | L63H | 0.999 |
| 7:35673247:C:A | G60V | 0.999 |
| 7:35673247:C:T | G60D | 0.999 |
| 7:35673254:A:C | Y58D | 0.999 |
| 7:35673256:A:T | V57E | 0.999 |
| 7:35673264:C:A | Q54H | 0.999 |
| 7:35673264:C:G | Q54H | 0.999 |
| 7:35694209:A:G | L41P | 0.999 |
| 7:35694218:T:A | K38I | 0.999 |
| 7:35694237:A:G | W32R | 0.999 |
| 7:35694237:A:T | W32R | 0.999 |
| 7:35694290:A:T | I14N | 0.999 |
| 7:35694296:A:G | L12P | 0.999 |
| 7:35633728:A:G | S395P | 0.998 |
| 7:35635157:C:G | G307R | 0.998 |
| 7:35635157:C:T | G307R | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000167416 (7:35692627 C>G,T), RS1000279058 (7:35650410 G>A), RS1000286267 (7:35650185 A>G), RS1000341804 (7:35637933 T>A,C), RS1000343012 (7:35637699 T>G), RS1000344036 (7:35662607 G>C), RS1000445704 (7:35644702 G>A,T), RS1000499007 (7:35673163 G>C), RS1000500429 (7:35662580 A>T), RS1000625897 (7:35657013 G>A), RS1000720248 (7:35656538 G>A), RS1000797452 (7:35686160 G>A), RS1000857747 (7:35674780 T>C), RS1000864699 (7:35681403 G>A), RS1000894050 (7:35639508 A>T)
Disease associations
OMIM: gene MIM:620829 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
55 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_756 | Obesity-related traits | 9.000000e-06 |
| GCST002386_6 | Cognitive function | 6.000000e-06 |
| GCST007045_29 | PR interval | 4.000000e-10 |
| GCST007226_11 | PR interval | 1.000000e-08 |
| GCST010321_118 | PR interval | 6.000000e-22 |
| GCST010774_14 | Essential hypertension (time to event) | 2.000000e-08 |
| GCST010796_1307 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-12 |
| GCST010796_1308 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
| GCST010796_1309 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-10 |
| GCST010796_1310 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-11 |
| GCST010796_1311 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-10 |
| GCST010796_3073 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-20 |
| GCST010796_3074 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-08 |
| GCST010796_3075 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-09 |
| GCST010796_3076 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-09 |
| GCST010796_3077 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-11 |
| GCST010796_3078 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-13 |
| GCST010796_3079 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-14 |
| GCST010796_3080 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-14 |
| GCST010796_3081 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-14 |
| GCST010796_3082 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-14 |
| GCST010796_3083 | Electrocardiogram morphology (amplitude at temporal datapoints) | 7.000000e-13 |
| GCST010796_3084 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-11 |
| GCST010796_3085 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-10 |
| GCST010796_3086 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-10 |
| GCST010796_3087 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-10 |
| GCST010796_3088 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-11 |
| GCST010796_3089 | Electrocardiogram morphology (amplitude at temporal datapoints) | 9.000000e-13 |
| GCST010796_3090 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-14 |
| GCST010796_3091 | Electrocardiogram morphology (amplitude at temporal datapoints) | 7.000000e-14 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003925 | cognition |
| EFO:0004462 | PR interval |
| EFO:0004918 | age at diagnosis |
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects cotreatment, decreases expression, increases expression | 3 |
| Valproic Acid | affects expression, decreases expression, increases expression | 3 |
| Cadmium Chloride | increases abundance, increases expression, decreases expression | 3 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Coumestrol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SR26 | HAP1 HERPUD2 (-) 1 | Cancer cell line | Male |
| CVCL_XP52 | HAP1 HERPUD2 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): essential hypertension